We won the Autoimmune Association's 2022 Patient Choice Awards!

Five startups were nominated and attendees of the second annual Community Summit voted for their favorite company.

On October 21st and 22nd, we attended the the Autoimmune Association's second annual Community Summit. We love the Autoimmune Association, because, like us, they're also trying to connect the dots across autoimmunity. The 2-day virtual event was completely free. They brought together clinicians, researchers, and patients to share resources, making it all the more accessible to the public.

The Autoimmune Association also invited startups! As a small biotech company, it's hard to keep up with the registration fees for large events or sponsoring smaller ones. The Association really made sure all the stakeholders could engage in the conversation.

Most critically, they elevated the most crucial voice, the patients'. Their Patients' Choice Awards presented a handful of nominated startups for the attendees of the event to vote on. The patients decided which startup they liked the most.

The virtual medal for the Autoimmune Association's Patients' Choice Awards went to ImYoo!

ImYoo was nominated by Lilly Stairs, a board member at the Association and founder of Patient Authentic, a patient-centric marketing company. We presented alongside 4 amazing startups: Paloma Health, Alira Health, Agora Health, and Progentec.

Paloma is designed to be a one-stop shop for managing your hypothyroidism.

Alira provides comprehensive consulting for healthcare and life sciences organizations.

Agora is a nifty app for following their gut health program.

Progentec currently specializes in lupus and multiple sclerosis, developing lab tests and apps that can assist clinicians and researchers.

ImYoo... you know what we do. In case you need a reminder, check out our submission video below.

ImYoo's video submission to the Autoimmune Association's 2022 Patient Choice Awards.

The votes came in and Lilly revealed that the winner won by just 1 vote.

And that 1 vote was for ImYoo!

It was the perfect metaphor for how every single person matters when it comes to biodiscovery. That's why we believe it's so important to collect multiple samples from people (longitudinal studies)! That's why we strive to baseline every study participant against themselves. We need to understand your biology, because your unique autoimmune system could hold the answers to the community's most burning questions.

Thank you for seeing that vision. Thank you for voting for ImYoo!

Your voice matters, your biology matters: register for our studies today.

IBD Study Launch!

Our second crowdsourced study is live.

We knew since day 1, that the rheumatoid arthritis study wouldn’t be our only crowdsourced research. After we made new friends at IBDCoach, we saw how proactive the IBD community is. Their Facebook group, Achieving Remission from Crohn’s Disease and Ulcerative Colitis, is active and engaged and curious. Perhaps, most importantly, the folks at IBDCoach — Andrew and Shae — are energetic and hopeful. (And they’re IBD Warriors themselves!)

These are all the qualities of promising citizen scientists, so we hopped into their online community. They answered our questions and we shared scientific research.

IBDCoach’s Facebook group, Achieving Remission from Crohn’s Disease and Ulcerative Colitis. (You can request to join by searching for it on Facebook!)

We also fell down a Reddit rabbit hole. (r/IBD, r/CrohnsDisease, and especially r/ostomy). Some Redditers could recap their whole health journey in a single comment. Their answers were humbling. There were many cautionary tales about preemptively coming off biologics, feeling fine, and suddenly losing it all — 1 flare could cost you your colon (aka: your ability to poop).

Our team asked some gastroenterologists about flares and we learned that there’s no sure-fire way to predict when they’ll start, how bad they’ll be, or how long they’ll last. As a result, it’s hard for doctors to be certain about the right course of treatment. And it’s hard for patients to know what to do, period.

“Do I need to cancel plans?” “Can I leave my house, or will I need to run back to the bathroom the second I reach the door?” Some flares could mean running to the bathroom up to 20 times in a single day! These are some of the first-hand accounts we heard talking to folks in-person last weekend at the Crohn’s and Colitis Foundation Take Steps event. While we volunteered, our team got a chance to chat with a lot of IBD Warriors. Folks of all ages shared the same sentiment, IBD flares are isolating.

During the COVID-19 pandemic, we all experienced some sense of isolation and saw those devastating effects on mental health. A lot of people said the uncertainty was the worst part of COVID lockdown, and we heard the same about IBD flares.

And what makes flares so isolating also makes them so hard to study. Until now.

Words from ImYoo team members on our IBD study investigating flares.

There aren’t many flare studies so far. With our decentralized immune studies, we want to change that. We want to mail you self-collection kits, so you can sample yourself during flares and stable conditions. Your flares are critical windows of opportunity to look at your immune cells.

We hope our decentralized immune study can remove some of the uncertainty associated with IBD. Maybe we’ll find biomarkers for predicting flare severity or duration. Maybe we’ll identify targets to guide treatment. Flares are largely uncharted territory, so we don’t know what we’ll find. What we know for sure is that we want to help IBD Warriors finally take charge. When a flare strikes, they can strike back, as citizen scientists. The science is in their hands.

If you’re an IBD Warrior, sign up to potentially join this study from home.

If you want to see the IBD study happen as soon as possible, make a donation to help us cover the costs. Our budget is clearly broken down on our Kernls page, so you can see where every dollar goes.

If this article gave you a newfound appreciation for your ability to poop, or you just think empowered patients are the future of scientific discovery, like we do, then share this article and share our page!

Our feature in Natalie Hayden’s blog, Lights Camera Crohn’s, where the flare study launch was first released on October 17th, 2022.

You can also follow along the flare study in our Medium thread.

Rheumatoid Arthritis Study Launch!

Our first crowdfunded and crowdsourced study is live & ready to share.

We brought together rheumatoid arthritis (RA) patients and designed a study based on their feedback! Our RA Working Group convened in July and narrowed down their top 5 research ideas. We opened up the voting on Reddit and Twitter, too. The enthusiasm of the community inspired us to continue on our path of citizen science!

To make this possible, we have partnered with Kernls. Kernls has helped scientists and non-profits raise money for their research. One of them being a success story on Long Covid: Patients funded a study that mattered to them, because they weren’t getting the answers they needed.

Crowdfunded studies done by biotech start-ups have the potential to move faster than the traditional academic or industry partners. Our goal with this crowdfunding campaign is to show that people can fund the studies that matter to them, and that we can make them happen in record time.

We discussed the importance of patient-treatment matching with rheumatoid arthritis clinicians. It’s become clear that doctors need better tools for personalizing which drugs they prescribe to their patients.

Visit our crowdfunding page and support in whichever way you can. Fund whichever amount you can budget. Sign up as a “Champion,” so you can amplify the campaign at zero cost. To show that we are committed to this cause, ImYoo is matching donations to our study!

And if rheumatoid arthritis isn’t your cup of tea, stay tuned for our other studies coming soon! They’ll all be posted to our Kernls page and announced in our newsletter (sign up here).

We’re starting with RA, but our campaign represents something much bigger: We’re building a people-driven biodiscovery ecosystem. The best research ideas come from lived experience, so we’re putting the tools in your hands. We envision a future where studies get kickstarted and executed as fast as the people want them. So what are you waiting for? Let’s make that future a reality!